Bangor Savings Bank’s Takeda Pharmaceutical TAK Stock Holding History

Bangor Savings Bank’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.98K	Hold	186	–	–	﹤0.01%	493
2026 Q1	$3.44K	Hold	186	–	–	﹤0.01%	494
2025 Q4	$2.9K	Hold	186	–	–	﹤0.01%	555
2025 Q3	$2.72K	Hold	186	–	–	﹤0.01%	503
2025 Q2	$2.88K	Hold	186	–	–	﹤0.01%	493
2025 Q1	$2.77K	Hold	186	–	–	﹤0.01%	488
2024 Q4	$2.46K	Hold	186	–	–	﹤0.01%	511
2024 Q3	$2.65K	Hold	186	–	–	﹤0.01%	506
2024 Q2	$2.41K	Hold	186	–	–	﹤0.01%	476
2024 Q1	$2.58K	Hold	186	–	–	﹤0.01%	463
2023 Q4	$2.65K	Hold	186	–	–	﹤0.01%	468
2023 Q3	$2.88K	Hold	186	–	–	﹤0.01%	483
2023 Q2	$2.92K	Hold	186	–	–	﹤0.01%	487
2023 Q1	$3.06K	Sell	186 -485	-72%	-$7.72K	﹤0.01%	473
2022 Q4	$11K	Hold	671	–	–	﹤0.01%	414
2022 Q3	$8K	Hold	671	–	–	﹤0.01%	437
2022 Q2	$10K	Buy	+671	New	+$9.58K	﹤0.01%	423

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Bangor Savings Bank's TAK Position: Q2 2026 in Review

Bangor Savings Bank held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 186 shares worth $2.98K. The position accounts for ﹤0.01% of the portfolio, ranked #493.

Bangor Savings Bank first reported a position in TAK in Q2 2022 and has held it in 17 quarters since. The position peaked at $11K in Q4 2022. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Bangor Savings Bank held 186 shares of Takeda Pharmaceutical worth $2.98K as of Q2 2026.
Bangor Savings Bank left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Bangor Savings Bank's portfolio in Q2 2026, its #493 holding.
Bangor Savings Bank first reported a position in Takeda Pharmaceutical in Q2 2022 and has held it in 17 quarters since.
Bangor Savings Bank's Takeda Pharmaceutical position peaked at $11K in Q4 2022.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.